Cary Street Partners Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.52M | Buy |
5,684
+346
| +6% | +$214K | 0.46% | 55 |
|
|
2024
Q2 | $2.95M | Buy |
5,338
+66
| +1% | +$36.5K | 0.43% | 62 |
|
|
2024
Q1 | $3.06M | Buy |
5,272
+44
| +0.8% | +$25.6K | 0.48% | 53 |
|
|
2023
Q4 | $2.77M | Buy |
5,228
+1,467
| +39% | +$779K | 0.48% | 59 |
|
|
2023
Q3 | $1.9M | Buy |
3,761
+46
| +1% | +$23.3K | 0.36% | 75 |
|
|
2023
Q2 | $1.94M | Sell |
3,715
-95
| -2% | -$49.6K | 0.36% | 75 |
|
|
2023
Q1 | $2.2M | Sell |
3,810
-160
| -4% | -$92.2K | 0.42% | 64 |
|
|
2022
Q4 | $2.19M | Buy |
3,970
+93
| +2% | +$51.2K | 0.44% | 59 |
|
|
2022
Q3 | $1.97M | Buy |
3,877
+53
| +1% | +$26.9K | 0.47% | 54 |
|
|
2022
Q2 | $2.08M | Sell |
3,824
-21
| -0.5% | -$11.4K | 0.49% | 57 |
|
|
2022
Q1 | $2.27M | Sell |
3,845
-3
| -0.1% | -$1.77K | 0.45% | 59 |
|
|
2021
Q4 | $2.57M | Sell |
3,848
-38
| -1% | -$25.4K | 0.55% | 50 |
|
|
2021
Q3 | $2.22M | Sell |
3,886
-113
| -3% | -$64.6K | 0.78% | 43 |
|
|
2021
Q2 | $2.02M | Sell |
3,999
-67,330
| -94% | -$34M | 0.48% | 64 |
|
|
2021
Q1 | $2.06M | Buy |
71,329
+4,503
| +7% | +$130K | 0.51% | 62 |
|
|
2020
Q4 | $1.9M | Buy |
+66,826
| New | +$1.9M | 0.56% | 56 |
|